Page last updated: 2024-11-08

streptidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

streptidine: component of streptomycin molecule; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

streptidine : An amino cyclitol that is scyllo-inositol in which the hydroxy groups at positions 1 and 3 are replaced by guanidino groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID439323
CHEMBL ID1742957
CHEMBL ID3781259
CHEBI ID27405
SCHEMBL ID936923
MeSH IDM0047474

Synonyms (26)

Synonym
dn7462s5br ,
streptidin
streptamine, n,n'-diamidino-
unii-dn7462s5br
1,1'-(2,4,5,6-tetrahydroxy-1,3-cyclohexylene)diguanidine
n,n'-diamidinostreptamine
1,1'-[(1r,2s,3s,4r,5r,6s)-2,4,5,6-tetrahydroxycyclohexane-1,3-diyl]diguanidine
CHEBI:27405
1,3-diguanidino-2,4,5,6-cyclohexanetetrol
n,n'-bis(aminoiminomethyl)streptamine
n,n'''-[(1r,2s,3s,4r,5r,6s)-2,4,5,6-tetrahydroxycyclohexane-1,3-diyl]diguanidine
streptamine, n,n'-bis(aminoiminomethyl)-
streptidine
C00837
85-17-6
dihydrostreptomycin sulfate impurity a [ep impurity]
streptidine [mi]
streptamine, n1,n3-bis(aminoiminomethyl)-
guanidine, n,n'''-(2,4,5,6-tetrahydroxy-1,3-cyclohexanediyl)bis-
SCHEMBL936923
CHEMBL1742957
CHEMBL3781259
2-[(1s,3r,4s,6r)-3-(diaminomethylideneamino)-2,4,5,6-tetrahydroxycyclohexyl]guanidine
rel-1,1'-((1r,2s,3s,4r,5r,6s)-2,4,5,6-tetrahydroxycyclohexane-1,3-diyl)diguanidine
Q27103112
DTXSID501018976

Research Excerpts

Treatment

ExcerptReferenceRelevance
"In streptidine-treated rats, the concentration of this compound was 1.0, 1.84 and 4.94 microg/ml on the 25th, 35th and 45th treatment days, respectively."( Streptidine, a metabolic derivative produced after administration of streptomycin in vivo, is vestibulotoxic in rats.
Granados, O; Meza, G, 2005
)
2.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-199023 (71.88)18.7374
1990's3 (9.38)18.2507
2000's4 (12.50)29.6817
2010's2 (6.25)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.40

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.40 (24.57)
Research Supply Index3.53 (2.92)
Research Growth Index4.26 (4.65)
Search Engine Demand Index39.34 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.40)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other33 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]